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Abstract
Background: Alcohol is a substantial risk factor for mortality according to the recent 2010 World Health Assembly
strategy to reduce the harmful use of alcohol which outlined the need to characterize and monitor this burden.
Accordingly, using new methodology we estimated 1) the number of deaths caused and prevented by alcohol
consumption, and 2) the potential years of life lost (PYLLs) attributable to alcohol consumption in Canada in 2005.
Methods: Mortality attributable to alcohol consumption was estimated by calculating Alcohol-Attributable
Fractions (AAFs) (defined as the proportion of mortality that would be eliminated if the exposure was eliminated)
using data from various sources. Indicators for alcohol consumption were obtained from the Canadian Alcohol and
Drug Use Monitoring Survey 2008 and corrected for adult per capita recorded and unrecorded alcohol
consumption. Risk relations were taken from the Comparative Risk Assessment within the current Global Burden of
Disease (GBD) study. Due to concerns about the reliability of information specifying causes of death for people
aged 65 or older, our analysis was limited to individuals aged 0 to 64 years. Calculation of the 95% confidence
intervals (CIs) for the AAFs was performed using Monte Carlo random sampling. Information on mortality was
obtained from Statistics Canada. A sensitivity analysis was performed comparing the mortality results obtained
using our study methods to results obtained using previous methodologies.
Results: In 2005, 3,970 (95% CI: 810 to 7,170) deaths (4,390 caused and 420 prevented) and 134,555 (95% CI: 36,690
to 236,376) PYLLs were attributable to alcohol consumption for individuals aged 0 to 64 years. These figures
represent 7.7% (95% CI: 1.6% to 13.9%) of all deaths and 8.0% (95% CI: 2.2% to 14.1%) of all PYLLs for individuals
aged 0 to 64 years. The sensitivity analysis showed that the number of deaths as measured by this new
methodology is greater than that if mortality was estimated using previous methodologies.
Conclusions: The mortality burden attributable to alcohol consumption for Canada is large, unnecessary, and
could be substantially reduced in a short period of time if effective public health policies were implemented. A
monitoring system on alcohol consumption is imperative and would greatly assist in planning and evaluating
future Canadian public health policies related to alcohol consumption.
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Background
Alcohol consumption is responsible for substantial mor-
bidity, mortality, and social problems in both developing
and developed countries [1,2]. Alcohol has been asso-
ciated with more than 230 International Classification of
Diseases version 10 (ICD 10) codes [2-5] and is
estimated to be the third most common cause of disabil-
ity adjusted life years lost (DALYs), responsible for 4.5%
of the DALYs worldwide [1]. In light of the considerable
harm associated with alcohol consumption as reflected
in these figures, member nations of the World Health
Organization (WHO) agreed during the 63
rd World
Health Assembly held in May 2010 to a global strategy
for reducing the harmful use of alcohol [6]. The recom-
mendations outlined in the global strategy include that
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consumption, that the importance of strengthening
information about alcohol consumption and alcohol-
related harms be recognized, and that this information
be effectively disseminated. Each member nation of the
WHO has the responsibility to monitor its country’s
alcohol consumption and alcohol-related harms data
(see also [7]).
Mortality caused by alcohol consumption in a popula-
tion can be estimated using an Alcohol-Attributable
Fraction (AAF). The AAF is defined as the proportion
of mortality that would be prevented if the exposure to
alcohol was completely eliminated from the population,
and can be expressed as follows:
AAF =
k 
i=0
Pi (RRi − 1)
k 
i=0
Pi (RRi)
(1)
where Pi represents the proportion of people in expo-
sure group i, and RRi is the relative risk of mortality for
group i compared to the reference group (in alcohol
research, often non-drinkers or lifetime abstainers). The
AAF is typically calculated for a number of drinking
categories (from i = 0 to k, where i = 0 is the reference
group and k + 1 is the number of drinking categories).
Previous papers that estimated the number of deaths
attributable to alcohol used categorical estimates of
alcohol consumption by calculating the AAFs for var-
ious diseases [8,9]. Alcohol consumption displays a
right-skewed distribution; calculating the number of
deaths caused and prevented by alcohol using categori-
cal or log transformation techniques will not completely
adjust for this right-skew, resulting in an underestima-
tion of mortality and morbidity [8,10,11]. In this paper,
mortality estimates for Canada in 2005 are presented
using new risk modelling methods that take into
account the right-skewed distribution of alcohol con-
sumption obtained from survey data. This method was
developed as part of the ongoing Global Burden of Dis-
ease (GBD) Comparative Risk Assessment and the US
Burden of Disease Study (see Murray et al.[12] for GBD;
see Rehm et al. [3,10] for a description of methodology).
In accordance with the World Health Assembly global
strategy, the objectives of this paper are 1) to estimate
the number of deaths caused and prevented by alcohol
consumption in Canada in 2005, and 2) to calculate the
potential years of life lost (PYLLs) attributable to alcohol
in Canada in 2005. Further objectives of this study are
3) to establish trends in alcohol-attributable mortality,
and 4) to compare the methods used in this paper with
previous methods used to calculate alcohol-attributable
mortality in Canada [8,13].
Methods
In order to estimate alcohol-attributable harms as out-
lined in the objectives, we collected data on the mea-
surement of the exposure, the risk relationships (RRs)
and AAFs, and the measurement of the outcome,
namely, mortality.
Exposure estimates
Alcohol consumption estimates were determined using
data derived from the Canadian Alcohol and Drug Use
Monitoring Survey (CADUMS) 2008 [14]. The
CADUMS 2008 was used since it is the largest nation-
ally representative survey on alcohol consumption and
was completed most recent to, but after, 2005. Further-
more, future iterations of this survey are planned, so
comparisons of exactly the same questions over time
should be possible. The survey methods utilized for the
CADUMS 2008 are described in detail elsewhere [15],
but, briefly, the CADUMS 2008 was a random digit dial-
ing telephone-based survey conducted over 8 months. In
total, 43,328 individuals were contacted, of whom 16,674
responded. Of those who responded, 16,640 individuals
provided a valid age and sex. A posteriori weighting of
those individuals who responded was performed by sex,
age, and region by triangulating the survey information
with the 2006 Canadian census. Of the participants who
were weighted, 15,801 provided a valid alcohol response
and age category, resulting in an overall participation
rate of 36.5%. When compared to the adult per capita
consumption of recorded alcohol in Canada in 2008, the
CADUMS 2008 coverage rate was 34%.
Drinking status in the CADUMS 2008 was defined as
“current drinkers” (individuals who consumed at least
one drink in the past year), “former drinkers” (indivi-
duals who consumed at least one drink in their lifetime,
but not within the last year), and “lifetime abstainers”
(individuals who had never consumed a drink in their
lives). Alcohol intake for “current drinkers” was mea-
sured in the CADUMS 2008 in terms of standard drinks
over the 7 days prior to the survey. A standard drink for
Canada was defined as 13.6 g of alcohol [16]. Since the
CADUMS 2008 did not measure alcohol consumption
in individuals younger than 15 years of age, and the
amount of alcohol consumed by people in this age cate-
gory is considered to be negligible, in our analysis we
categorized everyone younger than 15 years of age as a
lifetime abstainer. For binge drinking amounts we used
estimates from the 2001 and 2002 waves of the National
Epidemiological Survey on Alcohol and Related Condi-
tions (NESARC) as an estimate for Canadians [17].
The prevalence of alcohol consumption during preg-
nancy was estimated to be 13.3%, as obtained from the
Public Health Agency of Canada [18]. Average daily
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was calculated as a weighted average (weighted in pro-
portion to prevalence of births among women of differ-
ent age groups).
The estimated adult per capita consumption of
recorded and unrecorded alcohol consumption for
Canada in 2005 was based on information regarding
taxation and alcohol production export and import data,
generally considered to be the best estimate of overall
alcohol consumption in high-income countries [19]. Per
capita consumption estimates for unrecorded consump-
tion were calculated to be 19.5% of total alcohol con-
sumption, based on the research of Macdonald and
colleagues [20].
Upshifting and modelling alcohol consumption
To account for the undercoverage seen in the CADUMS
2008, we upshifted the mean intake in grams per day by tri-
angulating the data with per capita consumption estimates
of recorded and unrecorded alcohol for Canada in 2005.
This was achieved by multiplying the unshifted mean (for
each sex and age group) by the inverse of 90% of the cover-
age rate. As recommended by Rehm and colleagues [10],
we chose the inverse of 90% of the coverage rate in order
to account for alcohol not consumed due to, for example,
spillage, waste and breakage, and to account for under-
coverage of reported alcohol consumption that was most
likely present in the observational studies used in the meta-
analyses from which we obtained our RR estimates.
By using 1,001 alcohol distributions from 66 different
countries, Rehm and colleagues have shown that alcohol
consumption data from population surveys are best
continuously modelled using a Gamma distribution [10].
We thus used a Gamma distribution to model upshifted
alcohol consumption.
To model upshifted alcohol consumption in our study,
we also used the relationship between the mean alcohol
consumption and standard deviation of the alcohol dis-
tribution outlined by Rehm and colleagues (calculated
by regressing over 500 means (μ) and standard devia-
tions (s)). This relationship can be expressed as follows:
σmen =1 . 1 7 1∗ μmen (2)
σwomen = 1.258 ∗ μwomen (3)
Using these relationships, we calculated the standard
deviation of the upshifted Gamma distributions and
then used the mean and standard deviation to calculated
shape and scale parameters which are used to describe
the upshifted Gamma distribution [10].
Relative risks
The sources for the RRs are provided in the Additional
file 1. An outline of the causal relationship between
alcohol consumption and all alcohol-related causes of
morbidity and mortality is described by Rehm and col-
leagues [3]. Alcohol-attributable deaths were calculated
only for chronic diseases and injuries where a meta-ana-
lysis reported the existence of a continuous RR function.
Mortality data
Data on the number of deaths in Canada in 2005, coded
by the ICD 10, were obtained from Statistics Canada;
2005 data were the most current available [21]. Table 1
Table 1 Prevalence of alcohol consumption in Canada 2008 according to age, gender
Abstainers Former drinkers Current drinkers
Gender Age Percent 95% CI Percent 95% CI Percent 95% CI
Women 15-24 19.0 (13.4-24.5) 7.0 (3.2-10.7) 74.1 (67.9-80.3)
25-34 10.4 (6.8-14.0) 11.9 (8.5-15.2) 77.8 (73.2-83.3)
35-44 8.0 (5.4-10.5) 12.5 (9.5-15.5) 79.6 (75.8-83.3)
45-54 8.0 (5.5-10.4) 14.9 (11.9-17.9) 77.2 (73.5-80.8)
55-64 9.7 (7.2-12.2) 16.3 (13.3-19.3) 74.0 (70.4-77.6)
65-74 12.9 (9.5-16.3) 19.0 (14.8-23.3) 68.0 (63.0-73.0)
75+ 27.2 (21.8-32.5) 21.7 (16.8-26.5) 51.2 (45.2-57.1)
Men 15-24 13.1 (8.9-17.3) 3.4 (1.2-5.6) 83.5 (78.9-88.1)
25-34 5.8 (2.3-9.3) 9.4 (4.7-14.0) 84.9 (79.3-90.4)
35-44 5.3 (2.9-7.6) 8.6 (5.8-11.3) 86.2 (82.7-89.7)
45-54 5.3 (3.1-7.5) 12.0 (8.8-15.1) 82.8 (79.1-86.4)
55-64 3.7 (2.0-5.4) 17.7 (13.6-21.9) 78.5 (74.2-82.9)
65-74 8.0 (4.2-11.8) 22.8 (16.7-28.9) 69.2 (62.5-75.8)
75+ 7.5 (3.2-11.8) 20.0 (12.6-27.4) 72.5 (64.4-80.6)
Total 9.8 (8.9-10.7) 12.9 (11.9-13.8) 77.3 (76.1-78.6)
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role and where a meta-analysis exists quantifying the
continuous risk of the disease given a level of alcohol
consumption. Deaths in individuals over the age of 64
were not used in our main analysis, since specified
causes of death after this age were not considered reli-
able; however, when comparing the estimated deaths
with previous methods (see below in “Comparisons with
previous studies“), age categories above 64 were included
in mortality and PYLLs estimates.
Potential Years of Life Lost
PYLLs were calculated for Canada using the age specific
number of deaths in Canada prevented and caused by
alcohol consumption as determined by subtracting the
average age of death from the average life expectancy
for the age categorization, and by then multiplying this
number by the number of alcohol-attributable deaths
within the given age group. Age groups were cut off at
age 64 since specified causes of death after this age were
not considered reliable. The GBD study guidelines were
followed when calculating PYLLs values [22].
Calculating AAFs
The AAF for each cause of death and morbidity was cal-
culated by sex and age, taking into account the distribu-
tion of alcohol consumption and the prevalence of
different drinking statuses ("current drinkers,”“ former
drinkers,” and “lifetime abstainers”) as follows:
AAF =
Pabs + PformRRform +
150 
0
P(x)RR(x)dx − 1
Pabs + PformRRform +
150 
0
P(x)RR(x)dx
(4)
where Pabs represents the proportion of “lifetime abstai-
ners,” Pform the proportion of “former drinkers,” and P(x)
the probability distribution function of drinkers. RRform
represents the relative risk (RR) for “former drinkers,”
and RR(x) the RR function for a given alcohol consump-
tion in grams per day. A cap at an exposure of 150 g of
pure alcohol was used as a conservative measure, as very
few individuals consume more than 12 standard drinks
on a daily basis for an extended period of time; those
individuals were modelled as drinking 150 g.
The RRs for injuries were calculated according to Tay-
lor and colleagues by taking into account average con-
sumption, occasions of binge drinking, and the length of
time at risk after consumption (based on metabolism
data) [23]. The AAFs for average consumption were cal-
culated using formula 4, which incorporated an adjusted
RR for the time at risk; this adjusted RR value is calcu-
lated as follows:
RR(x) = Pdayatrisk ∗ Pdaysatrisk ∗ (RRCrude (x) − 1) +1 (5)
where Pdayatrisk (calculated based on alcohol intake ×
in grams per day) represents the proportion of a given
day during which a person drinks and is at risk, Pdaysa-
trisk (for average consumption this was set at 1) repre-
sents the percentage of days the person undertakes
drinking (binge or average), and RRcrude represents the
unadjusted risk ratio for injury given an alcohol con-
sumption level of x.
For binge consumption the AAFs for injuries were cal-
culated as follows:
AAF =
Pabs+former + Pcurrent(Non−Binge) + Pcurrent(Binge)RR(x) − 1
Pabs+former + Pcurrent(Non−Binge) + Pcurrent(Binge)RR(x) (6)
where Pabs+former is the proportion of lifetime abstainers
and former drinkers, and Pcurrent(Binge) and Pcurrent(Non-
Binge) are the prevalences of current drinkers who engage
and who do not engage in binge drinking, respectively.
RRbinge(x) represents the risk ratio for binge drinkers
given a binge amount of alcohol consumed, corrected for
both time at risk and number of drinking occasions.
Calculating the 95% confidence intervals for the AAFs
95% CIs for the AAFs were calculated from the variance
of 10,000 simulations [24]. For each simulation, esti-
mates were generated for the prevalence of “current
drinkers” and “former drinkers.” For all conditions
except injuries, a population mean was then calculated
based on the generated prevalence of “current drinkers”
and the generated mean alcohol consumption per day.
This population mean was then upshifted by triangulat-
ing the generated mean alcohol consumption with the
adult per capita consumption estimate. The standard
deviation (SD) of the upshifted Gamma distribution, as
well as the shape parameter estimates, were calculated
based on the relationship between the upshifted mean
and the SD as reported by Rehm and colleagues [10].
For instances of low birth weight, the prevalence of
drinkers during pregnancy was assumed to be 13.3% as
reported by the Public Health Agency of Canada; we
assumed that mothers who consumed alcohol during
pregnancy displayed a similar distribution to the
upshifted distribution of drinkers [18]. The 10,000 AAFs
for injuries were calculated based on simulations which
generated estimates for average consumption, prevalence
of current drinkers, binge consumption, prevalence of
binge drinkers, and number of drinking occasions for
people who engage in binge drinking.
Comparisons with previous studies
The gross number of deaths and the PYLLs for Canada
for 2005 (excluding the number of deaths and PYLLs
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methods described by Rehm and colleagues [8,10]. For
comparability with previous studies, the same age cate-
gorizations were used [8,13]. 15,531 participants of the
CADUMS 2008 provided a valid, exact age, and infor-
mation concerning their alcohol consumption, and were
therefore included in our analysis. Gross estimates of
attributable mortality were calculated which did not
include data regarding mortality or PYLLs prevented by
alcohol.
All statistics were performed using R version 2.10.1.
Results
Tables 1 and 2 provide an overview of 1) the estimated
volume of alcohol consumption, both unshifted esti-
mates and upshifted estimates, 2) the prevalence of “cur-
rent drinkers,”“ former drinkers,” and “lifetime
abstainers,” and 3) the average number of drinking occa-
sions per week by age and sex. As expected, men drank
more than women, and alcohol consumption was the
highest in the younger age groups.
Table 3 provides the net number of alcohol-attributa-
ble deaths caused (represented by a positive number) or
prevented (represented by a negative number) by alco-
hol consumption in Canada in 2005. The 3,958 net alco-
hol-attributable deaths among individuals between the
ages of 0 and 64 constituted 7.7% (95% CI: 1 6% to
13.9%) of all deaths in Canada for these age groups in
2005. This can be broken down into 9 net deaths for
Canadians between the ages of 0 and 14 (8 deaths attri-
butable to low birth weight due to alcohol consumption
by the mother during pregnancy, and one death due to
ethanol and methanol toxicity, undetermined intent)
and 3,949 deaths for people between the ages of 15 and
64. Overall, there were 4,382 (95% CI: 2,967 to 7,184)
deaths attributable to alcohol (1,111 (25.4%) for women;
3,271 (74.6%) for men), and 424 (95% CI: 0 to 2,154)
deaths prevented by alcohol (108 (25.3%) for women;
316 (74.7%) for men). The largest contributors to alco-
hol-attributable mortality were unintentional injuries,
malignant neoplasms, and digestive diseases. The most
important specified causes of preventable deaths attribu-
ted to alcohol consumption were liver cirrhosis (868
deaths; 595 males, 273 females) and motor vehicle acci-
dents (663 deaths; 588 males, 75 females).
A large variation was observed for the average age of
d e a t hb yc a t e g o r ya n db ys e x .T h ea v e r a g ea g eo fa l c o -
hol-attributable death was 47 years (46 years for men
and 50 years for women). The youngest average age of
death attributable to alcohol (excluding conditions aris-
ing during the perinatal period) resulted from motor
vehicle accidents (35 years for men and 29 years for
women). With respect to alcohol-prevented deaths, the
mean age was 54 years (54 years for men and 53 years
for women).
In Canada in 2005, a net total of 134,555 (95% CI:
36,690 to 236,376) potential years of life were lost for
individuals between the ages of 0 and 64 years (see
Table 4 for the number of PYLL attributable to alcohol
by gender and age in Canada in 2005). This constituted
8.0% (95% CI: 2.2% to 14.1%) of the PYLLs in Canada
for individuals between 0 and 64 years of age. Of these
PYLLs, 11,536 (95% CI: 16 to 56,527) were prevented by
alcohol, while 146,091 (95% CI: 93,217 to 236,392) were
Table 2 Consumption by age before and after upshifting estimates
Raw estimates (Current Drinkers) Corrected estimates (Current Drinkers Number of drinking occasions per week
Gender Age Mean (g/day) 95% CI Mean (g/day) 95% CI Number 95% CI
Women 15-24 9.67 (2.1-17.2) 26.4 (24.4-28.3) 0.80 (0.58-1.02)
25-34 5.46 (3.5-7.4) 18.2 (16.8-19.5) 0.75 (0.61-0.88)
35-44 3.63 (3.1-4.2) 12.1 (11.6-12.7) 0.82 (0.69-0.95)
45-54 5.03 (4.1-5.9) 16.7 (16.0-17.4) 1.03 (0.89-1.18)
55-64 4.55 (3.9-5.2) 15.1 (14.4-15.9) 1.06 (0.91-1.12)
65-74 4.57 (3.4-5.7) 15.2 (14.0-16.4) 1.01 (0.77-1.26)
75+ 3.97 (2.9-5.0) 13.2 (12.0-14.5) 0.83 (0.59-1.07)
Men 15-24 11.68 (8.3-15.0) 38.5 (35.5-41.6) 0.92 (0.73-1.12)
25-34 12.80 (9.8-15.8) 40.0 (36.6-43.3) 1.39 (1.14-1.64)
35-44 9.14 (7.5-10.8) 29.7 (28.1-31.3) 1.40 (1.21-1.59)
45-54 12.01 (8.8-15.2) 36.4 (34.4-38.4) 1.63 (1.42-1.86)
55-64 10.58 (8.7-12.4) 34.7 (32.6-36.7) 1.68 (1.42-1.93)
65-74 11.34 (7.5-15.2) 37.5 (34.1-40.9) 1.52 (1.15-1.89)
75+ 7.92 (5.7-10.1) 25.9 (23.1-28.7) 1.77 (1.29-2.25)
Total 5.79 (4.6-7.0) - - 1.15 (1.09-1.21)
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Page 5 of 12Table 3 Alcohol-attributable mortality for Canada in 2005
0-1 4
years
15 - 24
years
25 - 34
years
35 - 44
years
45 - 54
years
55 - 64
years
Total
Condition M F M F M F M F M F M F M F Overall
Total, all causes of death
Total, all causes of death 5 4 375 84 355 46 429 102 843 345 948 422 2955 1003 3958
Malignant neoplasm’s
Mouth and oropharynx cancers 0 0 1 0 2 1 11 4 53 13 93 14 160 32 192
Esophageal cancer 0 0 0 0 1 0 6 0 38 5 102 10 147 15 162
Liver cancer 0 0 0 0 2 0 4 0 23 6 38 11 67 17 84
Laryngeal cancer 0 0 0 0 0 0 1 0 14 2 31 3 46 5 51
Breast cancer 0 0 0 0 0 5 0 35 0 114 0 148 0 302 302
Colon cancer 0 0 0 0 1 0 3 2 15 11 41 27 60 40 100
Rectum cancer 0 0 0 0 0 0 2 1 7 4 16 6 25 11 36
Total 0 0 1 0 6 6 27 42 150 155 321 219 505 422 927
Diabetes
Total (diabetes mellitus) 0 0 0 3 0 1 -2 -4 1 15 7 12 6 27 33
Neuro-psychiatric conditions
Alcoholic psychoses 0 0 2 1 5 1 13 2 19 8 27 8 66 20 86
Alcohol abuse 0 0 1 0 3 1 11 6 30 10 30 14 75 31 106
Alcohol dependence syndrome 0 0 0 0 2 1 22 6 74 19 65 20 163 46 209
Degeneration of nervous system due to alcohol 0 0 0 0 0 0 0 0 2 0 3 0 5 0 5
Epilepsy 0 0 4 2 7 2 7 2 9 5 6 3 33 14 47
Alcohol polyneuropathy 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total 0 0 7 3 17 5 53 16 134 42 131 45 342 111 453
Cardiovascular disease
Hypertensive disease 0 0 0 0 0 0 3 0 15 3 16 6 34 9 44
Ischemic heart disease 0 0 0 0 -5 -1 -37 -5 -104 -16 -168 -33 -314 -55 -369
Alcohol cardiomyopathy 0 0 0 0 0 0 4 0 13 1 16 5 33 6 39
Cardiac arrhythmias 0 0 0 1 1 0 2 1 7 3 16 5 26 10 37
Ischemic stroke 0 0 0 0 1 -1 1 -9 6 -16 12 -23 20 -49 -29
Hemorrhagic and other non-ischemic stroke 0 0 0 0 0 1 3 2 11 9 47 19 61 31 93
Total 0 0 0 1 -3 -1 -24 -11 -52 -16 -61 -21 -140 -48 -185
Digestive diseases
Alcoholic gastritis 0 0 0 0 0 0 1 0 2 0 2 0 5 0 5
Cirrhosis of the liver 0 0 0 0 8 5 69 33 217 105 302 130 596 273 868
Acute and chronic pancreatitis 0 0 0 1 0 0 1 0 9 1 10 2 20 4 25
Chronic pancreatitis (alcohol-induced) 0 0 0 0 1 0 3 1 5 2 6 1 15 4 19
Total 0 0 0 1 9 5 74 34 233 108 320 133 636 281 917
Conditions arising during the prenatal period
Low birth weight: as defined by the global burden of
disease
4400000 0 0 0 0 0 4 4 8
Fetal alcohol syndrome (dysmorphic) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Excess alcohol blood levels 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total 4 4 0 0 0 0 0 0 0 0 0 0 4 4 8
Unintentional injuries
Motor vehicle accidents 0 0 205 46 137 12 78 3 105 8 62 6 587 75 664
Poisonings 0 0 10 3 27 3 35 3 34 5 8 2 114 16 130
Falls 0 0 6 0 5 0 6 0 17 1 21 2 55 3 58
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to alcohol-attributable PYLLs was motor vehicle acci-
dents at 29,955 PYLLs (25,874 males, 4,081 females),
while unintentional injuries totalled 46,861 PYLLs
(40,812 males, 6,049 females). The greatest contributor
to prevented PYLLs attributable to alcohol was ischemic
heart disease with 9,774 PYLLs prevented (8,185 males,
and 1,589 females).
Overall, alcohol impacted men more than women;
9.3% (95% CI: 1.3%-17.2%) of all deaths and 10.0% (95%
CI: 2.4%-17.7%) of all PYLLs among men were attributa-
ble to alcohol consumption. In contrast, 5.0% (95% CI:
1.9%-8.7%) of all deaths and 5.1% (95% CI: 2.0%-8.5%)
of all PYLLs among women were attributable to alcohol
consumption.
Table 5 presents for the years 1992, 2002 and 2005 in
Canada 1) the gross number of deaths, 2) the number of
deaths attributable to alcohol among all individuals and
among individuals younger than 70 years of age, and 3)
the PYLLs attributable to alcohol. A percentage increase
in the gross number of deaths was not observed from
2002 to 2005; however, the number of deaths attributa-
ble to alcohol among individuals younger than 70 years
of age, as well as the total number of PYLLs attributable
to alcohol, increased between 1992 and 2005. Corre-
spondingly, the per capita consumption of recorded and
unrecorded alcohol increased from 9.20 l per person per
year in 2002 to 9.32 l per person per year in 2005. 1992
data showed an even greater per capita consumption of
recorded and unrecorded alcohol (9.58 l per person per
year); however, it is important to note that unrecorded
consumption was based on current estimates and not
on population estimates for 1992.
Table 5 also outlines the number of deaths and PYLLs
attributable to alcohol consumption for the WHO
regions of America A (Canada, Cuba and the United
States) and the Americas, and for the world as a whole.
In 2005, of the total deaths in Canada, a higher percen-
tage of these deaths (all ages) were attributable to alco-
hol consumption than was the case for America A in
2004, but Canada had a lower percentage of total deaths
Table 3 Alcohol-attributable mortality for Canada in 2005 (Continued)
Fires 0 0 1 1 2 0 2 0 5 1 3 1 13 3 17
Accidental poisonings and exposure to alcohol 0 0 4 2 4 3 9 3 13 2 10 0 40 10 50
Drowning 0 0 8 1 6 0 5 0 5 0 3 0 27 1 30
Other Unintentional injuries 0 0 27 3 27 1 27 1 42 3 31 3 154 11 166
Total 0 0 261 56 208 19 162 10 221 20 138 14 990 119 1115
Intentional injuries
Self-inflicted injuries 0 0 80 16 89 7 107 8 124 13 58 5 458 49 507
Intentional self-poisoning by and exposure to alcohol 0 0 0 0 0 0 2 1 2 0 0 1 4 2 6
Homicide 0 0 24 3 25 2 12 1 9 1 6 1 76 8 83
Other intentional injuries 0 0 1 0 1 0 0 0 1 0 0 0 3 0 3
Total 0 0 105 19 115 9 121 10 136 14 64 7 541 59 599
Infectious and parasitic diseases
Total (tuberculosis) 0 0 0 0 0 0 1 0 2 1 2 1 5 2 8
Respiratory infections
Total (pneumonia) 0 0 1 1 1 1 6 2 12 5 22 12 42 21 63
Ethanol and methanol toxicity, undetermined intent 1 0 0 0 2 1 11 3 6 1 4 0 24 5 29
Table 4 Potential years of life lost (PYLLs) attributable to
alcohol in Canada in 2005 by gender and age
Gender Age groups
(years)
PYLLs Lower 95%
CI
Upper 95%
CI
Women 0-14 313 98 528
15-24 5244 30 14414
25-34 2614 1144 4084
35-44 4456 2656 6256
45-54 11577 5735 17418
55-64 10347 3495 17199
Total 34551 13160 59899
Alcohol-attributable years of life lost per 100 000 women = 706
Men 0-14 397 176 618
15-24 21744 10639 32849
25-34 17268 7779 26756
35-44 16551 5848 27255
45-54 24541 2635 46447
55-64 19503 -3546 42552
Total 100004 23531 176478
Alcohol-attributable years of life lost per 100 000 men = 249
Total
PYLLs
134555 36690 236376
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Page 7 of 12in 2005 attributable to alcohol consumption than was
observed for the Americas and for the world as a whole
in 2004. In 2005 Canada had a lower percentage of the
total PYLLs which were attributable to alcohol con-
sumption than was the case for America A, the Ameri-
cas, and the world as a whole in 2004.
Discussion
Alcohol consumption has a significant negative impact
on public health. Alcohol accounted for far more deaths
than the number of deaths prevented by alcohol for
Canadians
0 to 64 years of age. This paper improves upon pre-
vious estimates of mortality by using new methodology
to 1) account for the undercoverage of alcohol con-
sumption in the CADUMS 2008, which represented
only 34% of recorded alcohol consumption in Canada,
2) take into consideration the right-skewed distribution
of alcohol consumption, and 3) calculate 95% CIs. Addi-
tionally, we used updated risk ratio estimates in this
study, as well as estimates for mortality for new disease
categories such as colon cancer, rectal cancer, and
tuberculosis [8,9]. Implementation of these new methods
described by Rehm and colleagues [10] resulted in a
higher estimated mortality attributable to alcohol com-
pared to previous methods due primarily to the addi-
tional disease categories included in our analysis. The
inclusion of new disease categories and use of new
methodology allows for a more accurate characterization
of alcohol-attributable mortality, which can potentially
lead to better public health policies aimed at reducing
alcohol-attributable harms.
This paper’s analysis has its limitations. For our study
we did not include all aspects of harms caused by the
drinking of others, such as due to motor vehicle acci-
dents and workplace injuries, which recently have been
shown to constitute a large proportion of the burden of
injury attributable to alcohol, as no meta-analyses exist
that describe an RR which can be used to calculate this
burden [25]. Due to the absence of available data on the
incidence of certain events, such as the incidence of
fetal loss during pregnancy attributable to alcohol con-
sumption, our analysis was restricted to deaths and
PYLLs and does not provide a complete picture of the
effects of alcohol on all aspects of health. Additionally,
we did not estimate the number of deaths for Canadians
over 65 years of age since specified causes of death for
people in this age group were considered to be unreli-
able. If we had included in our analysis the number of
deaths for Canadians aged 65 years and older, the num-
ber of net deaths attributable to alcohol would have
risen from 3,969 to 8,953 and the number of PYLLs
would have risen from 134,555 to 172,255; however, as
indicated above, primary information concerning the
causes of death for Canadians over 65 years of age is
considered to be unreliable.
For this study, we used cross-sectional estimates of the
average volume of alcohol consumption, not taking into
consideration individuals’ past and current patterns of
drinking as distinct from volume, with the exception of
injury which incorporated binge drinking estimates.
W h i l er e s t r i c t i o n so nv o l u m em a yn o tb ei m p o r t a n tf o r
certain diseases, patterns of drinking impact the risk of
diseases such as ischemic heart disease and other cardi-
ovascular diseases [4,26,27]. In addition, not including
past patterns of drinking is problematic for studying the
role of alcohol in a person’s developing malignant neo-
plasms as the time between exposure to a carcinogen
and exhibiting symptoms of cancer can range from
between 15 and 30 years [28]. Liver cirrhosis at the indi-
vidual level is mainly affected by long-term heavy drink-
ing; however, immediate effects decreasing its incidence
are seen at the country level after a short time when
alcohol consumption decreases dramatically [29].
Accordingly, public policies aimed at reducing alcohol-
attributable harms will not only have an immediate
impact on alcohol-related harms but will also have long-
term benefits.
Limitations in the study design, sampling, and
response rates of the CADUMS 2008 led to an under-
coverage of the resulting estimates of alcohol consump-
tion in Canada. For example, the CADUMS 2008
excluded people living in the Northwest Territories
(which have a greater proportion of individuals suffering
from alcohol abuse problems compared to the rest of
Canada), and excluded homeless and institutionalized
individuals, as well as those individuals without a home
phone. The inherent problems with the CADUMS 2008
were adjusted for in our study by triangulating the sur-
vey data with the per capita alcohol consumption esti-
mate (according to the methods of Rehm and colleagues
[10]).
The response rate for the CADUMS 2008 survey was
relatively low, with an overall response rate of 36.5%.
However, it has been previously demonstrated that
higher response rates do not necessarily change the
resulting distribution of alcohol consumption when the
response rate varies between 30% - 60% and similar
sampling methods are used [19,30]. Moreover, since we
triangulated survey data with per capita consumption
data for our study, underreporting of alcohol consump-
tion should not be problematic [31].
Undercoverage of alcohol may be present in both the
survey alcohol exposure data and the studies used in the
meta-analyses to calculate the RR functions. This under-
coverage may lead to an overestimation of the alcohol
RR functions for all diseases; however, the effects of
these two instances of undercoverage differ. Only
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and construct validity) affects the RR functions. Under-
coverage in exposure estimates derived from survey data
arises from measurement error, non-response to the
alcohol survey, and from the exclusion of certain popu-
lations from the survey. Since we do not know the
extent of undercoverage caused by measurement error
in the studies that were used in the meta-analyses, it is
impossible to determine the coverage rate to which our
survey data should be standardized in order to correct
the RR functions. Since it is very likely that the under-
coverage in epidemiological studies is much less than in
population surveys [32], we corrected the undercoverage
of the CADUMS to 90% of the per capita consumption
in order to account for the overestimated RRs calculated
from observational studies.
If we did not adjust for the undercoverage of the sur-
vey data, the number of deaths attributable to alcohol
consumption would be 47.9% of the total number of
deaths calculated after adjustment to 90% of per capita
consumption, resulting in a calculation of 1,896 net
deaths from alcohol. It should be noted, however, that
adjustment of per capita consumption data across coun-
tries is necessary if the mortality figures are to be com-
parable across countries.
Our study is also limited by the RRs used to calculate
the number of alcohol- attributable deaths and PYLLs in
Canada for 2004. These limitations stem from the meta-
analyses of the adjusted RRs [33]. There are two poten-
tial problems with the RR functions that could affect the
results of our study. First, there is an assumption that
RRs for alcohol consumption are stable across countries.
While this assumption is plausible for chronic diseases,
which are mainly determined by biological relationships
(as demonstrated by the low heterogeneity in the
chronic disease RR meta-analyses), this assumption is
less plausible for injuries where social influences will
affect the RRs (e.g. traffic injury depends on highway
safety standards, density of cars, etc.). As most of the
RRs for injury are estimated based on data from high-
income countries with similar environmental conditions
to Canada, these RR estimates are valid for our study.
S e c o n d ,t h eu s eo fa d j u s t e dR R sm a yo v e r e s t i m a t et h e
true RRs as observed by Flegal and others [34-36]; how-
ever, the size of the potential bias has recently been
shown to be relatively small [37].
Regardless of our study’s limitations and assumptions,
alcohol is clearly a major contributor to mortality and
PYLLs, and has a significant public health impact in
Canada. In contrast to tobacco-related mortality, the
average age of death resulting from alcohol consump-
tion is much lower [2,13], such that mortality due to
alcohol consumption occurs primarily in adults of work-
ing age and results in a negative economic impact. This
was also observed in our study, as alcohol was responsi-
ble for 7.7% of all deaths and 8.0% of all PYLLs for peo-
ple between 0 and 64 years of age.
A monitoring system on alcohol consumption and
alcohol-related harms is imperative as the burden of
alcohol-attributable harms in Canada is unnecessary and
could be reduced in a relatively short period of time if
effective public health policies were implemented
Table 5 Mortality differences attributable to alcohol for different methodologies and times for Canada and other
countries
Country Study Methods Year Alcohol-
attributable
deaths
% of all
Deaths
All deaths
caused under
70*
% of all deaths
caused under 70
PYLLs* % of
all
PYLLs
Canada* Single et al., 1996
[10]
Single et
al., 1996
[10]
1992 6,701 3.41% 4,913 6.64% 186,257 6.05%
Canada* Patra et al., 2007
[11]
Rehm et al.,
2006 [12]
2002 8,103 3.62% 5,061 7.56% 191,136 6.18%
Canada* Current Study Rehm et al.,
2006 [12]
2005 8,312 3.61% 5,338 8.13% 197,040 6.25%
Canada* Current Study Current
Study
2005 10,284 4.47% 5,613 8.55% 209,084 6.63%
Canada Current Study Rehm et al.,
2006 [12]
2005 6,454 2.80% - - 171,700 5.45%
America A (WHO
region AMR A)
Rehm et al., 2008
[Rehm et al., 2010]
Rehm et al.,
2006 [12]
2004 55,000 1.99% - - 1,224,000 6.09%
Americas (WHO
region AMR)
Rehm et al., 2008
[Rehm et al., 2010]
Rehm et al.,
2006 [12]
2004 347,000 5.60% - - 6,845,000 10.21%
World Rehm et al., 2010
[Rehm et al., 2010]
Rehm et al.,
2006 [12]
2004 2,255,000 3.80% - - 40,863,000 4.38%
* Estimates are based on the gross number of deaths caused by alcohol and do not include those prevented except for: America A, Americas, and world
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Page 9 of 12[38,39]. These policies could include taxation, additional
and/or stronger sanctions to combat impaired driving,
and specific measures to decrease aggression and vio-
lence [39-41]. Rehm and colleagues analyzed the effects
of these interventions in Canada for 2002 and found
that an increase in price of 25% would result in a
decrease of 59 net deaths and more than 1,500 net
PYLLs [42,43]. By reducing in Canada the maximum
acceptable blood alcohol content while operating a
motor vehicle from 0.08% to 0.05%, Rehm and collea-
gues found that there would be 173 fewer net deaths
and more than 7,000 fewer net PYLLs (a 4.1% reduction
and a 5.0% reduction, respectively from the baseline sce-
nario) [42,43]. A real world example of government pol-
icy affecting mortality due to alcohol consumption was
observed in Russia during the Gorbachev anti-alcohol
campaign, where annual per capita consumption of pure
alcohol fell from 14.2 l in 1984 to 10.7 l in 1987. As a
result of this decrease in alcohol consumption, all cause
mortality rates for 40-44 year olds decreased by 39% for
men and by 29% for women and alcohol-related mortal-
ity rates for 40-44 year olds decreased by 63% for men
and by 63% for women between 1984 and 1987 [44].
Each of the policy measures suggested above has been
shown to be effective in jurisdictions outside of Canada
which face similar epidemiological profiles of mortality
due to alcohol consumption [39-41,45]. For the above
Canadian examples, the noted reductions in mortality
represent a net estimate and, thus, incorporate potential
increases in the incidence of diseases where alcohol
exhibits a protective effect.
A comprehensive alcohol consumption and alcohol-
attributable harms monitoring system in Canada would
allow for evaluation of the effectiveness of public health
policies and, once established, could be used to identify
those areas where targeted alcohol policies would have
the greatest impact. Finally, such a system would help to
estimate alcohol-attributable harms in the future using
time-trend analysis. Monitoring systems on the harms
of alcohol should include the resulting social harms. In
some regions it is possible that the social harms asso-
ciated with alcohol consumption may exceed the burden
of mortality.
Conclusion
The estimated mortality and PYLLs attributable to alco-
hol consumption in Canada in 2005 is substantial, with
alcohol-attributable deaths from motor vehicle acci-
dents, malignant neoplasm and digestive diseases being
the largest contributors to this burden. The novel meth-
ods described in this paper allow for the most accurate
characterization of the burden of mortality attributable
to alcohol, and are directly comparable to estimates
from other countries that use the same method of
adjusting alcohol consumption and to estimates
obtained in GBD reports. As outlined in the World
Health Assembly strategy to reduce the harmful use of
alcohol, it is imperative to quantify and monitor the
burden of mortality due to alcohol consumption in
order to formulate and evaluate public health policies
aimed at reducing alcohol’s harmful effects. Accordingly,
we propose that the estimates presented in this paper
act as a baseline measurement for a monitoring system
for Canada.
Additional material
Additional file 1: Outlines the sources for the RRs by ICD 10 code
[46-62].
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